That genetic factors contribute to the etiology of schizophrenia is no longer debated; the nature and magnitude of that contribution, however, are still open for discussion. In this article, concordance rates for twin studies of schizophrenia are reviewed as one means of assessing the magnitude of the genetic contribution. Using only those studies in which representative samples were used and zygosity was determined with reasonable certainty, the pairwise concordance rate for schizophrenia was found to be 28 percent for monozygotk (MZ) and 6 percent for dizygotic (DZ) twins. Review of twin studies of other central nervous system diseases reveals that schizophrenia is most similar to multiple sclerosis (MZ concordance rate 27%). Although genetics remains as the single most clearly defined etiological factor in schizophrenia, the question remains whether we are overestimating the magnitude of the genetic contribution.
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theories of schizophrenia in recent years, the focus of the debate has shifted to a closer examination of the role of genetics in relation to other biological theories of schizophrenia's etiology.
The standard methods used to assess genetic contributions to the etiology of diseases are to compare concordance rates in monozygotic (MZ) versus dizygotic (DZ) twins, to study family pedigrees, to study the disease incidence in adoptees, and linkage analysis. Of these approaches, the twin method has a long history and has received the most attention in psychiatry. In 1812 Dr. Benjamin Rush commented on the similarity of the brains of identical twins who had both committed suicide (Price 1978), and in 1859 Dr. J. Moreau described identical twins in France with very similar psychotic symptoms (Galton 1875). Following publication of Sir Francis Galton's classic 1875 article describing how studies of twins "afford means of distinguishing between . . . the effects of nature and of nurture" (p. 391), those with an interest in the genetics of mental disorders increasingly turned their attention toward twins.
For twin studies of any disease to provide useful information regarding the relative contribution of genetics, two criteria must be fulfilled. First, zygosity must be established with relative certainty. The questionnaire method (e.g., "Were the twins as alike as two peas in a pod?"), photographs, and dermatoglyphics can establish zygosity with a high level of certainty if used carefully, but red cell typing, widely used only since World War II, is a more reliable method. More recently deoxyribonudeic acid (DNA) methods to determine zygosity have become available.
Second, the sample must be sufficiently representative so the results are not biased. Vogel and Motulsky, in their textbook Human Genetics (1986), distinguish four types of twin samples: (1) birth registers in which every twin in a population is ascertained; (2) limited representative sampling in which "all twin individuals are ascertained within a population of affected patients of the disease under investigation" (p. 211), for example, the identification of Canadian twins with multiple sclerosis by surveying all clinics that treat that disease; (3) individual case reports; and (4) accumulated case reports. The last two samples may produce biased results because twins who are MZ and those that are concordant for a disease tend to be selectively recalled and therefore referred more frequently than DZ or discordant pairs. Concordant twins are also known to volunteer more readily in response to advertisements. The following review will therefore be restricted to twin studies that meet criteria for careful ascertainment of zygosity and are based on either case registers or limited representative samples.
In analyzing twin studies of CNS diseases, four other methodological problems must be addressed. First, many of these disorders in addition to schizophrenia are thought to be syndromes rather than specific diseases. For example, epilepsy comprises several etiological subgroups and concordance rates in such a heterogeneous sample may reflect genetic factors operating for only one subgroup. Second, the definition of concordance can be problematic in many disorders. For example, cotwins in autism may have significant lags in language development but no other signs of that disease, co-twins in Parkinson's disease may have a benign essential tremor, and co-twins in multiple sclerosis may have magnetic resonance imaging (MRI) changes indicative of that disease but no clinical symptoms.
Third, there is a problem of defining limits to the risk period and determining when no additional twin pairs will become concordant. For example, in some diagnostic systems for schizophrenia, age 45 has been established as an upper limit for the onset of the disease, but other diagnostic systems permit a later age of onset. Similar problems exist for epilepsy, multiple sclerosis, and Parkinson's disease.
Finally, twin studies of most CNS diseases use pairwise rates to express concordance; each twin pair is treated as a separate unit and concordance is calculated as a percentage of the pairs in which both twins are sick, for example, 3 of 10 or 30 percent. Many schizophrenia researchers, geneticists, and epidemiologists have argued that probandwise concordance rates are preferable. According to Gottesman and Shields (1982) , in the proband method "some pairs are counted twice if both members of the pair are affected and if each member was ascertained independently" (p. 72). Thus, by the proband method if (in the example given above) both twins in one of the concordant pairs had been ascertained independently, the probandwise concordance rate would be 4 of 11 or 36 percent. Only probandwise concordance rates can be compared with incidence rates in nontwin populations. However, because only pairwise concordance rates are available for virtually all twin studies of diseases other than schizophrenia and because this article will compare twin studies only with each other and not with nontwin VOL 18, NO. 2, 1992 161 populations, pairwise concordance rates will be used.
Concordance Rates in Twin Studies of Schizophrenia
The first large research study of twins with schizophrenia was carried out by Luxenberger in Germany in the 1920s (Luxenberger 1928 Essen-Moller's 1941 Swedish twin study was the first one to meet minimum criteria for adequate sampling and zygosity determination. He identified twin pairs using local parish birth registrations and used consecutive admissions to mental hospitab over 11 years to achieve an unbiased sample. He was also the first researcher of twins to use red blood cell groups to confirm zygosity, to examine most pairs himself, and to publish extensive case histories. He followed up his twins over 30 years to ascertain complete concordance rates. In 1970 he reported these rates as 4 of 8 (50%) for MZ twins and 2 of 27 (7%) for DZ twins (EssenM6ller 1970).
The Slater and Shields twin study was based on twin pairs identified in 10 mental hospitals in London (Slater and Shields 1953) . The study appears to include a reasonably complete sample although it was somewhat biased toward more severely ill twin pairs because it was hospital based. Many researchers have asserted that greater severity of illness in an index twin increases the chances that the second twin will become ill (e.g., Shields 1977, 1982 (Tienari 1975) . Zygosity was carefully established in the three studies, with questionnaires and photographs used for twins who had died, and case histories were published to clarify questions of diagnosis. The concordance rates reported were as follows: Tienari MZ, 3 of 20 (15%) and DZ, 3 of 42 (7%); Kringlen MZ, 14 of 45 (31%) and DZ, 14 of 172 (8%); Fischer MZ, 5 of 21 (24%) and DZ, 4 of 41 (10%).
Another twin study of schizophrenia based on a continuous sample was that by Gottesman and Shields (1972) , who identified twins among 45,000 admissions to the Maudsley Hospital in London between 1948 and 1964. Like the Slater and Shields study, it was hospital based, but it included outpatients as well as inpatients and thus was less biased toward severity (and therefore concordance). Unlike the Scandinavian studies by Tienari, Kringlen, and Fischer, however, it did not include twins with schizophrenia in whom neither twin had been treated at the hospital. Gottesman and Shields (1982) determined zygosity "by blood-grouping and fingerprinting in most pairs" (p. Ill) and they personally interviewed most of them. Diagnoses were made by a six-judge diagnostic panel. Using strict diagnostic criteria for schizophrenia, the concordance rate for MZ twins was 9 of 22 (41%) and for DZ twins, 3 of 33 (9%).
The single American twin study to meet minimal criteria for sampling and zygosity derived from the registry set up in 1959 by the National Academy of Sciences (NAS) and the National Research Council (NRC), covering all American military personnel who served in World War II and the Korean War. As such, the register is exclusively male and includes only individuals accepted for military service. It is therefore biased against individuals with an early onset of schizophrenia, the very individuals who are more likely to have a severe form of the disease and thus more likely to become concordant. The NAS-NRC twin study is strongly biased in favor of lower concordance rates (Kendler and Robinette 1983) . Diagnoses were taken from Veterans Affairs (VA) records and included only those cases who were either treated while in the service or later applied for VA disability pensions. This would appear to bias the register toward including more severe cases and excluding less severe cases, a bias that produces a higher concordance rate. Zygosity was ascertained by blood typing in 5 percent of the twin pairs, fingerprints and questionnaires in 36 percent, and questionnaires only in the remainder. In 19 percent of the twin pairs with schizophrenia, zygosity could not be reliably determined. As of 1981 the veterans in the NAS-NRC register were aged 54 to 64, beyond the age of risk for schizophrenia. At that time the concordance rate for MZ twins was 30 of 164 (18%) and for DZ twins, 9 of 268 (3%).
The most recent twin study of schizophrenia concordance rates was carried out by Onstad et al. (1991) , using the Norwegian Twin Register. The twins were born between 1936 and 1960 and did not overlap the Norwegian twin cohort previously studied by Kringlen. Zygosity was established by a new questionnaire, which was said to be 95 percent reliable, and blood analyses in doubtful cases. Diagnoses were established by two separate rates using DSM-III-R (American Psychiatric Association 1987) criteria. The researchers reported a concordance rate for MZ twins of 8 of 24 (33%) and for DZ twins, 1 of 28 (4%).
In summary, since the late 1930s there have been eight twin studies of concordance rates for schizophrenia that meet minimal criteria for sampling and zygosity ascertainment. Of these studies, the Scandinavian case register studies are methodologically the strongest while the Slater and Shields study (with a sample bias toward higher concordance) and the NAS-NRC study (with an overall sample bias toward lower concordance) are methodologically the weakest. More recent twin studies such as those in the United States by Pollin and colleagues (Pollin and Stabenau 1968; Belmaker et al. 1974 ), Torrey and colleagues (Suddath et al. 1990) , and in England by Reveley and colleagues (1984) have not attempted to collect uninterrupted samples or ascertain concordance rates.
The pairwise concordance rate for the aggregated eight studies, summarized in table 1, is 28 percent for MZ and 6 percent for DZ. If the Gottesman-Shields and NAS-NRC samples are not included, the rate is 31 percent for MZ and 8 percent for DZ. This MZ rate is lower than the 50 percent rate quoted in many American textbooks of psychiatry for the following reasons: (1) exclusion of twin studies that did not meet minimal criteria for unbiased sample or zygosity determination (those by Luxenberger, Rosanoff and colleagues, Kallmann, and Inouye); (2) use of pairwise instead of probandwise concordance rates; (3) no use of an age correction factor because most twins in the studies cited had passed through the maximum risk period for the disease; and (4) acceptance of diagnostic criteria for schizophrenia used by the original investigators rather than trying to re-diagnose cases retrospectively or including schizophrenia spectrum disorders as concordant. Mental Retardation. Mental retardation is a syndrome of cognitive dysfunction known to accompany many chromosomal and genetic abnormalities and thought to be caused by a wide variety of prenatal and perinatal factors. The incidence of mental retardation among twins is twice that among single births, and it frequently coexists with cerebral palsy, autism, and epilepsy.
Two studies of mental retardation in twins have been done in case registers or limited representative samples. A study based on the Denmark twin register reported concordance rates for MZ twins of 12 of 18 (67%) and for DZ twins 0 of 49 (Harvald and Hauge 1965) . The other study was carried out as part of the collaborative perinatal project of the National Institute of Neurological Diseases and Stroke. A sample of 55,043 pregnant women was prospectively followed and their offspring were extensively evaluated until they reached age 7. Among the 508 twin pairs in which zygosity could be clearly established, there were 40 pairs in which at least 1 was mentally retarded (IQ < 70). The concordance rate among MZ twins was 6 of 12 (50%) and among DZ twins, 7 of 28 (25%) (Broman et al. 1987 ). Bipolar Disorder. Bipolar disorder is a syndrome of mood disturbance with episodes of mania and/or major depression that are often accompanied by psychotic features. Although it is readily distinguishable in its classic forms, in its less classic forms bipolar disorder blends imperceptibly into schizophrenia and diagnosis may be difficult.
The major twin study of bipolar disorder was carried out by Bertelsen and colleagues (1977) in Denmark, using the national twin registry and central psychiatric register. Diagnostic criteria were relatively broad. Zygosity was established in approximately half the cases with red cell typing and in the other half (in which one twin was deceased) using questionnaires. Smaller twin studies of bipolar disorder using registers or limited representative samples were also carried out by Essen-Moller in Sweden, Slater and Shields in England, Kringlen in Norway, and Torgersen in Norway (Bertelsen et al. 1977; Torgersen 1986 (Griffiths 1967) failed to ascertain zygosity and included large numbers of stillbirths in the samples. More recently Petterson and colleagues (in press), using the Western Australia case register for cerebral palsy, reported data on 46 twin pairs in which 1 or both twins had cerebral palsy. Among the MZ twins, 6 of 15 (40%) were concordant and among the DZ twins, 0 of 21 were concordant. Males predominated among twin pairs with cerebral palsy by a ratio of 2 to 1.
Autism. Autism is a disorder of social relationships and language development that also includes stereotypic or repetitive movements. Its onset is within the first 5 years of life. Recent studies of the fragile X syndrome suggest that genetics plays a significant etiological role in some cases of autism. A twin study of autism carried out by Folstein and Rutter (1977) in England met criteria for a limited representative sample; it attempted to "obtain information on all school age autistic twin pairs in Great Britain" (p. 298) by canvassing psychiatric, pediatric, and educa- Among 21 twin pairs so identified, the concordance rate for MZ twins was 4 of 11 (36%) and for DZ twins, 0 of 10. When concordance criteria were broadened to include cognitive and social impairment (e.g., markedly delayed speech development and mental retardation) in the co-twin the concordance rate increased for MZ twins to 9 of 11 (82%) but remained unchanged for DZ twins, suggesting that many of the MZ, but not the DZ co-twins, had a lesser form of the autistic disorder, not the full syndrome. Males outnumbered females in this study 3 to 1.
The other reported twin study of autism was carried out by Ritvo and colleagues (1985) in the United States by advertising in the newsletter of the National Society for Autistic Children and thus should be regarded as accumulated case reports sample. The authors reported high concordance rates for MZ twins (22 of 23, 96%) and DZ twins (4 of 17, 24%), but Folstein and Rutter (1988) characterized the study as "misleading in its assertions and conclusions" (p. 11) because of its biased sample and methodology.
Poliomyelitis. Poliomyelitis is a disease caused by a picornavirus that may range from inapparent (no symptoms but antibody response indicates infection) or abortive (minor systemic symptoms but no CNS involvement) to nonparalytic (CNS signs and symptoms but no paralysis) or paralytic (flaccid weakness in one or more muscle groups). It is known to be a chronic disorder with CNS symptoms recurring as much as three decades after the initial infection.
A twin study of polio cases in Finland from 1930 to 1936 reported an MZ concordance rate of 1 of 4 and a DZ concordance rate of 0 of 13 (Herndon and Jennings 1951); however, zygosity in this study was not carefully ascertained. The definitive twin study of poliomyelitis was carried out by Herndon and Jennings (1951) in North Carolina on all reported cases of the disease between 1940 and 1948. Clinical details were ascertained by contacting treating physicians and public health nurses and by examination of birth records. Zygosity was confirmed by photographs, red cell typing, and dermatoglyphics; the twins were all examined and extensive family histories taken. Twins were included in the data analysis only if they were living together at the onset of the disease, thereby suggesting that both had been exposed. In 46 twin pairs studied, the MZ concordance rate was 5 of 14 (36%) and the DZ concordance rate was 2 of 31 (6%).
Congenital Anomalies of CNS. Congenital anomalies are a measure of prenatal events that may be caused by chromosomes (e.g., Down's syndrome), genes (e.g., polycystic kidneys), infections (e.g., rubella), drugs (e.g., thalidomide), or other chemicals (e.g., alcohol). In the majority of cases, however, the etiology of the congenital anomaly is unknown. The incidence of congenital anomalies among twin births is higher than among single births; in fact, it has been said that "in itself MZ twinning can be considered a congenital malformation" (Myrianthopoulos 1975, p. 6 ).
There have been two studies of congenital anomalies in limited representative samples in which CNS anomalies were reported separately. The first was reported by Myrianthopoulos (1975) as part of the collaborative perinatal project previously described. Of the MZ twin pairs with CNS congenital anomalies, one of four (25%) was concordant for anomalies but not for type of malformation (one had hydrocephaly and the other had macrocephaly). The remaining three MZ twin pairs were discordant (for anencephaly, microcephaly, and "a bizarre combination of CNS malformations" [p. 22] ). Of the DZ twin pairs with CNS anomalies, zero of five were concordant (discordance was for anencephaly, microcephaly, hydrocephaly, macrocephaly, and encephalocele). Myrianthopoulos concluded that "concordance in twins in general for CNS malformations is low" (p. 22). The other limited representative sample was reported by Cameron and colleagues (1983) who conducted a prospective investigation of 1,074 consecutive twin pairs born in Birmingham, England, and another 350 twin pairs born in Ghent, Belgium. From this series, one of two (50%) of the MZ twin pairs born with CNS congenital anomalies was concordant (for hydrocephalus) and the other was discordant (for anencephaly).
Although the numbers of CNS congenital anomalies from these two studies are small, the results are reinforced by three other studies of larger numbers of twins that did not ascertain zygosity carefully and so cannot be directly compared. Record and McKeown (1951) studied 20 twin pairs'with CNS anomalies born in Birmingham between 1940 and 1947; Hay and Wehrung (1970) reported on 88 CNS anomalies among 199,700 twin pairs identified by the National Cleft Lip and Palate Intelligence Service; and Stevenson and colleagues (1966) described 12 CNS anomalies among 5,022 twin pairs in a World Health OrganizaHon (WHO) multicenter study. For these three studies combined, the concordance rate for presumed MZ twin pairs was 12 of 75 (16%) and for presumed DZ twin pairs was 1 of 45 (2%), confirming the low concordance rate for congenital CNS anomalies reported in the two studies with better methodology. In summarizing their findings, Hay and Wehrung (1970) noted: "The literature on congenital CNS malformation contains many individual case reports of nonconcordant MZ pairs, the conclusion usually being that the genetic contribution to the etiology of these conditions is low" (p. 669). This low concordance rate for congenital anomalies of the brain is surprising in view of the fact that rare cases of hydrocephaly are known to be genetically transmitted (Edwards 1961 Heltberg (1987) Finland Kinnunen et al. (1987 Kinnunen et al. ( , 1988 NAS-NRC Eldridge and Ince (1984) have even speculated that twins may acquire a protective factor from their mother in utero.
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Tourette Syndrome and Alzheimer's Disease. A twin study exists for each of these CNS disorders, but in neither case is it based on representative samples. A twin study of Tourette syndrome by Price and colleagues (1985) was based on cases recruited through advertising to members of the Tourette Syndrome Association. The reported concordance rate was 16 of 30 (53%) for MZ twins and 1 of 13 (8%) for DZ twins. When criteria for concordance were broadened to include any tics in the co-twin, the concordance rates increased to 77 percent for MZ twins and 23 percent for DZ twins.
There has also been one twin study of Alzheimer's disease by Nee and colleagues (1987) , but the twins were recruited "through contacts with the Alzheimer's Disease and Related Disorders Association, families of patients, Mothers of Twins Clubs, and physicians" (p. 359) and thus were accumulated case reports. The reported concordance rate was 7 of 17 (41%) for MZ twins and 2 of 5 (40%) for DZ twins. A followup of "senescent" twin pairs by Jarvik and colleagues (1980) of twins originally recruited by Kallmann with radio and newspaper advertisements is limited because it uses a biased sample and has diagnostic problems. A preliminary report from the NAS-NRC registry found a 60 percent concordance rate for MZ twins with Alzheimer's disease (Breitner et al. 1990) ; when this study is completed, it should help clarify the concordance rate for this disease.
Discussion
Although twin studies are only one means to assess genetic aspects of diseases (with adoption studies, pedigree studies, and linkage analysis being other means), twin studies are especially useful because they have been carried out for so many different diseases (see table 4). These studies thus afford an opportunity to roughly compare the genetic contribution to different conditions. It is acknowledged that schizophrenia, like epilepsy, mental retardation, cerebral palsy, and some other conditions discussed earlier, is almost cer- 
Note.-CNS = central nervous system. tainly comprised of a variety of etiological subgroups. Also, given subgroups may theoretically range from exclusively genetic to nongenetic in origin. Despite such heterogeneity, the pairwise concordance rate for schizophrenia when compared with other CNS conditions for which twin data are available is roughly comparable to multiple sclerosis and is slightly lower than congenital anomalies of the CNS, poliomyelitis, or autism. The MZ twin concordance rate for bipolar disorder is exactly twice the rate for schizophrenia (56% vs. 28%).
The question remains as to whether we are overestimating the genetic contribution to schizophrenia. Genetics remains the only clearly defined etiological factor for this disease; this may be because genetics are the most important factor or merely because the other etiological factors have not yet been identified. Our assumptions about the answers to such questions are important because they define both the advice provided to families regarding genetic counseling about schizophrenia as well as research strategies that are used to further explicate this disease.
